Document |
Document Title |
WO/2022/084254A1 |
The present invention describes a mixture of isomeric aldimines of the formulae (Ia), (Ib) and (Ic) in which the ratio of the trans,trans isomer (Ia) to the sum of the cis,trans isomer (Ib) and the cis,cis isomer (Ic) is in the range of ...
|
WO/2022/084252A1 |
The present invention describes a moisture-curing polyurethane composition comprising – at least one isocyanate-functional polymer with a content of monomeric isophorone diisocyanate of below 0.5 weight-%, obtained from the reaction of...
|
WO/2022/073525A1 |
A method and device for integrating an ammoximation reaction and separation. In the method, titanium-silicon molecular sieve is used as a catalyst; an ammoximation reaction of a ketone, hydrogen peroxide and ammonia is carried out to gen...
|
WO/2022/069553A1 |
The invention relates to a method for producing benzaldehyde oximes of the general formula (I) and to the use thereof as important precursors for the synthesis of agrochemical and pharmaceutical active substances.
|
WO/2022/063351A1 |
The subject of the invention is azulene hydrazide-hydrazones bearing 2-hydroxyaryl group of general formula I. These compounds show selective cytostatic effect and therefore they can be used for the preparation of medicaments for the tre...
|
WO/2022/064454A1 |
The present invention discloses a process for the synthesis of compound of formula (VII) or a salt thereof, wherein, R, R1, R2, R3, R4a and R4b are as defined in the detailed description. The process further comprises the synthesis of an...
|
WO/2022/058580A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|
WO/2022/046676A1 |
Hemorrhage and vascular instability can be induced by thrombolytic and anti-coagulant therapies. Presented herein, in certain aspects, are methods for the treatment and/or prevention of hemorrhage and vascular instability that comprise a...
|
WO/2022/037525A1 |
Disclosed are an acetophenone oxime compound and a preparation method therefor, and specifically disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
|
WO/2022/034426A1 |
The present invention relates to a process for the preparation of a key intermediate and other intermediates useful for the synthesis of Siponimod, a drug used for the treatment of multiple sclerosis. Object of the invention are also sai...
|
WO/2022/013009A1 |
The present invention relates to the use of strobilurin type compounds of formula (I) and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome ...
|
WO/2022/008303A1 |
The present invention relates to the use of strobilurin type compounds of formula (I) and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome ...
|
WO/2022/002567A1 |
Imine, obtainable by reacting (i) an amino-functionalized polyoxyalkylene, the polyoxyalkylene chains being a copolymer that consists of oxyethylene- and oxypropylene units, and these polyoxyalkylene chains carry (preferably per molecule...
|
WO/2021/249928A1 |
The present invention relates to the use of strobilurin type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b ...
|
WO/2021/239568A1 |
The present invention relates to a process for the preparation of substituted 4-(N'-hydroxy- carbamimidoyl)benzoic acids, which can be obtained by nitrilase catalyzed hydration of substituted terephthalonitriles of formula (II) in an aqu...
|
WO/2021/235164A1 |
A linear optical material according to an aspect of the present disclosure is represented by formula (1). At least one selected from the group consisting of R1 to R5, at least one selected from the group consisting of R6 to R10, and at l...
|
WO/2021/235165A1 |
A nonlinear optical material according to one aspect of the present invention is represented by formula (1).
|
WO/2021/227206A1 |
Disclosed are a diethylamine-containing azine hydrazine compound, a preparation method therefor and an application thereof. The method comprises: performing a heating reaction on a diphenylhydrazine derivative and a diethylamine-containi...
|
WO/2021/225982A1 |
Disclosed herein are small molecule SOS1 allosteric site inhibitors, pharmaceutical compositions, and methods of use thereof.
|
WO/2021/212460A1 |
Disclosed by the present application is a method for autocatalytic preparation of 2,5-furandicarboxaldehyde oxime. The method for the autocatalytic preparation of the 2,5-furandicarboxaldehyde oxime comprises: reacting 2,5-furandicarboxa...
|
WO/2021/208201A1 |
The present invention provides an external micro-interface ammoximation reaction system and method. The external micro-interface ammoximation reaction system comprises an oximation reactor, a reaction clear liquid buffer tank, a tert-but...
|
WO/2021/208199A1 |
The present invention provides a reaction system and method for ammoximation and tert-butyl alcohol recovery. The reaction system comprises an oximation reactor, a reaction clear liquid buffer tank, a tail gas absorption tower, a tert-bu...
|
WO/2021/208200A1 |
The present invention provides a built-in micro-interface ammoximation reaction system and method, the system comprising an oximation reactor, a reaction supernatant buffer tank, a tert-butanol recovery tower, an extraction tank, a water...
|
WO/2021/190567A1 |
Disclosed in the present invention are a diphenyl sulfide ketone oxime ester compound, a preparation method therefor, a composition and use thereof. A diphenyl sulfide ketone oxime ester photoinitiator has the characteristics of high sen...
|
WO/2021/177359A1 |
This ammonia decomposition method is a method for obtaining nitrogen, protons, and electrons by oxidative decomposition of ammonia in the presence of a base, using as a catalyst a salen-manganese complex in which manganese is used as a b...
|
WO/2021/175886A1 |
The present invention relates to a fusing agent, comprising a compound of formula (I), a three-dimensional (3D) printing kit including the compound of formula (I) and A method for three-dimensional (3D) printing, including selectively ap...
|
WO/2021/168582A1 |
The present invention generally relates to a chemical process under flow conditions for manufacturing compounds which absorb ultraviolet (UV) radiation and protect biological materials as well as non-biological materials from damaging ex...
|
WO/2021/158046A1 |
The present invention relates to a pharmaceutical composition comprising gossypol or a derivative thereof as an active ingredient for prevention or treatment of a neurological disorder. A decrease in the level of the inhibitory neurotran...
|
WO/2021/153786A1 |
The present invention provides a compound having an excellent control effect against pests. A compound represented by formula (1) of the present invention (in the formula, Q represents a group indicated by Q1 or a group indicated by Q2 (...
|
WO/2021/153794A1 |
The present invention provides a method of controlling soybean rust fungus that has an F129L amino acid substitution in the mitochondrial cytochrome b protein. The compound represented by formula (I) can be used to control soybean rust f...
|
WO/2021/148426A1 |
The present invention relates to compounds of formula (I) as defined herein. The compounds are suitable for protection against ultraviolet (UV) radiation. Further, the present invention is concerned with compositions comprising at least ...
|
WO/2021/122594A1 |
The present invention relates to compounds having one of the following formulae (I) or (II): (I) (II), and to uses thereof.
|
WO/2021/096811A1 |
Disclosed herein are tucaresol derivative compound and composition containing the same. Also disclosed herein are methods of enhancing immune response in a subject by administering the tucaresol derivative compound or by co-administering...
|
WO/2021/081677A1 |
Provided are compounds and salts having a structure of Formula (I) or (II): (I), and (II) wherein: both of the chiral carbon atoms denoted by "*" are both in the R configuration or both in the S configuration. Compounds and salts of Form...
|
WO/2021/082278A1 |
Disclosed are a class of fluorine-containing α-diimine nickel complexes for preparing a polyolefin elastomer and intermediates thereof. The class of complexes have a single catalytic active center, the molecular weight of a polymer can ...
|
WO/2021/081624A1 |
The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigm...
|
WO/2021/031984A1 |
Disclosed are a carboxylic acid oxime ester compound and the use thereof as a herbicide and for preparing a microbicide. The carboxylic acid oxime ester compound is as represented by general formula I:
|
WO/2021/035176A1 |
The invention provides a compound of formula (I): wherein R1, R2, and R3 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), methods for preparing compounds of formula (I),...
|
WO/2021/023144A1 |
Disclosed in the present invention is a novel fluorenoxime ester compound, a preparation method therefor, a photoinitiator containing the fluorenoxime ester compound, and a photosensitive resin composition. The fluorenoxime ester compoun...
|
WO/2021/009026A1 |
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...
|
WO/2020/262648A1 |
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...
|
WO/2020/258971A1 |
Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new cl...
|
WO/2020/245468A1 |
The present invention relates to compounds useful as modulators of sirtuins, in particular as activators of SIRT1. Furthermore, the invention refers to the medical use of such compounds, in particular in the prevention and/or treatment o...
|
WO/2020/240391A1 |
The present invention discloses an improved process for the preparation of bromo-formimine compounds. More particularly, the present invention discloses an improved process for the preparation of bromo-formimine compounds, wherein bromin...
|
WO/2020/234128A1 |
The invention concerns a process for preparing an aldol ester of the formula (I), characterized in that at least one carboxylic anhydride of the formula (II) is reacted with at least one aldol of the formula (III) with heating in the pre...
|
WO/2020/237079A1 |
In alternative embodiments, provided are uncharged bis-oxime antidotes that cross the blood-brain barrier (BBB) to catalyze the hydrolysis of organophosphate (OP)-inhibited human acetylcholinesterase (hAChE) in the central nerve system (...
|
WO/2020/234069A1 |
The disclosure relates to 1-(bicyclo[2.2.1]hept-5-en-2-yl)ethan-1-one O-methyl oxime possessing powerful green fruity anisic banana olfactory properties. The invention furthermore refers to fragrance compositions comprising it and to a m...
|
WO/2020/214095A1 |
The present invention relates to, in general, methods of fabricating a covalent organic framework (COF) and the COF thereof. In particular, the method comprises forming an acylhydrazone bond with an optionally substituted 2-alkoxybenzohy...
|
WO/2020/202940A1 |
Provided is a catalytic mixture with sufficient catalytic efficiency, wherein pressure loss is small when the catalytic mixture fills a flow reactor and a reactive solution is caused to flow therethrough, and the catalytic efficiency and...
|
WO/2020/193387A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|